These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38315384)

  • 1. Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders.
    Pennington KM; Simonetto D; Taner T; Mangaonkar AA
    Curr Hematol Malig Rep; 2024 Feb; ():. PubMed ID: 38315384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic cell transplantation for telomere biology diseases: A retrospective single-center cohort study.
    Nichele S; Bonfim C; Junior LGD; Loth G; Kuwahara C; Trennephol J; Funke VAM; Marinho DE; Koliski A; Rodrigues AM; Mousquer RTG; Fasth A; Lima ACM; Calado RT; Pasquini R
    Eur J Haematol; 2023 Sep; 111(3):423-431. PubMed ID: 37259830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a prospective screening strategy to identify adults with a telomere biology disorder among those undergoing lung transplant evaluation for interstitial lung disease.
    Banaszak LG; Smith-Simmer K; Shoger K; Lovrien L; Malik A; Sandbo N; Sultan S; Guzy R; Lowery EM; Churpek JE
    Respir Med; 2023 Dec; 220():107464. PubMed ID: 37951311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Hematopoiesis and Myeloid Neoplasms in the Context of Telomere Biology Disorders.
    Ferrer A; Mangaonkar AA; Patnaik MM
    Curr Hematol Malig Rep; 2022 Jun; 17(3):61-68. PubMed ID: 35524933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Liver and Kidney Transplantation in a Patient With Telomere Biology Disorder: A Case Study.
    Choudhary D; Lekshmon KS; Singh C; Subramani VN; Singh Y; Mitra S; Sekar A; Malik M; Bhagat N; Shiva Kumar SP; Taneja S; Gupta V; Ramachandran R; Singh S; Nada R; Kenwar D; Duseja AK; Yadav TD; Malhotra P; Sharma A
    J Clin Exp Hepatol; 2024; 14(3):101355. PubMed ID: 38389866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations.
    Warsame F; Simonetto DA
    Curr Hematol Malig Rep; 2024 Apr; 19(2):75-81. PubMed ID: 38372947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registry.
    Tometten M; Kirschner M; Isfort S; Berres ML; Brümmendorf TH; Beier F
    Orphanet J Rare Dis; 2021 Sep; 16(1):395. PubMed ID: 34565437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.
    Balakumaran A; Mishra PJ; Pawelczyk E; Yoshizawa S; Sworder BJ; Cherman N; Kuznetsov SA; Bianco P; Giri N; Savage SA; Merlino G; Dumitriu B; Dunbar CE; Young NS; Alter BP; Robey PG
    Blood; 2015 Jan; 125(5):793-802. PubMed ID: 25499762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant.
    Marini BL; Markstrom D; Frame D
    J Oncol Pharm Pract; 2017 Jun; 23(4):255-263. PubMed ID: 26970572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis.
    Metheny L; de Lima M
    Expert Rev Hematol; 2019 Jan; 12(1):47-60. PubMed ID: 30582393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant.
    Ruggeri A; Sun Y; Labopin M; Bacigalupo A; Lorentino F; Arcese W; Santarone S; Gülbas Z; Blaise D; Messina G; Ghavamzadeh A; Malard F; Bruno B; Diez-Martin JL; Koc Y; Ciceri F; Mohty M; Nagler A
    Haematologica; 2017 Feb; 102(2):401-410. PubMed ID: 27758821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management.
    Rahi MS; Jindal V; Pednekar P; Parekh J; Gunasekaran K; Sharma S; Stender M; Jaiyesimi IA
    Ther Adv Infect Dis; 2021; 8():20499361211039050. PubMed ID: 34434551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Second Unrelated Donor Hematopoietic Stem Cell Transplant in a Patient With Dyskeratosis Congenital After First Graft Rejection.
    Giardino S; Faraci M; Lanino E; Morreale G; Terranova P; Palmisani E; Dufour C; Miano M
    Exp Clin Transplant; 2023 Apr; 21(4):368-374. PubMed ID: 28969530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantation.
    Lahav M; Uziel O; Kestenbaum M; Fraser A; Shapiro H; Radnay J; Szyper-Kravitz M; Avihai S; Hardan I; Shem-Tov N; Nagler A
    Transplantation; 2005 Oct; 80(7):969-76. PubMed ID: 16249747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.